SCHEMBL30295377

SCHEMBL30295377

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3ccc4ccccc43)[C@H](OC(=O)c3ccc[nH]3)[C@@H](O)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31083369 1.00 — —
SCHEMBL30295273 0.89 HTR3E (0.32) —
SCHEMBL25101152 0.89 HTR3E (0.32) —
SCHEMBL30295374 0.85 — —
SCHEMBL31108454 0.85 — —
SCHEMBL30295218 0.82 OPRM1 (0.32) —
SCHEMBL25100658 0.82 OPRM1 (0.32) —
SCHEMBL25101187 0.81 RXFP1 (0.31) —
SCHEMBL30295285 0.81 RXFP1 (0.31) —
SCHEMBL30295223 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392037-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS Boyce Thompson Institute for Plant Research Inc. (US) 2024-07-03 — — EP disclosed
WO-2023028350-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) 2023-03-02 — — WO disclosed
Send feedback